Cara Therapeutics
CARA
#10367
Rank
HK$63.13 M
Marketcap
HK$41.41
Share price
-2.56%
Change (1 day)
1,871.59%
Change (1 year)

Earnings for Cara Therapeutics (CARA)

Earnings in 2024 (TTM): -HK$0.5 Billion

According to Cara Therapeutics 's latest financial reports the company's current earnings are HK$7.13 Million. , an increase over its 2023 earnings that were of -HK$0.9 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cara Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -HK$0.49 Billion-45.49%
2023 -HK$0.9 Billion31.6%
2022 -HK$0.69 Billion-1.74%
2021 -HK$0.7 Billion-1754.28%
2020 HK$41.92 M-104.82%
2019 -HK$0.87 Billion44.32%
2018 -HK$0.61 Billion30.09%
2017 -HK$0.47 Billion1.86%
2016 -HK$0.46 Billion131.86%
2015 -HK$0.2 Billion39.38%
2014 -HK$0.15 Billion9120.41%
2013 -HK$1.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Trevena
TRVN
-HK$0.25 Billion-50.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-HK$0.62 Billion 26.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
HK$29.3 M-105.99%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-HK$80.09 Million-83.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$92.26 B-18,975.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$252.18 B-51,692.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-HK$2.12 Billion 332.81%๐Ÿ‡บ๐Ÿ‡ธ USA